亞盛醫藥-B(06855.HK)獲納入恆生指數系列成份股
格隆匯 8 月 17日丨亞盛醫藥-B(06855.HK)發佈公告,公司已獲恆生指數有限公司選為以下指數系列的成份股,並將於2020年9月7日生效:1)恆生綜合指數;2)恆生香港上巿生物科技指數;及3)恆生醫療保健指數。
恆生綜合指數涵蓋在聯交所主板上市證券總市值最高的95%,提供了一項全面的香港市場指標。恆生綜合指數採用流通市值加權法計算,可以用作發行指數基金、互惠基金及表現量度基準。恆生香港上市生物科技指數旨在反映香港上市生物科技公司的整體表現,包括透過聯交所證券上市規則第18A章在聯交所上市的公司。恆生醫療保健指數提供一項市場參考指標,反映在香港上市、主要經營醫療保健業務證券的整體表現。
董事會認為,此次獲選為恆生指數有限公司上述指數系列的成份股,充分反映了資本市場對公司業務、股票流通性及發展前景的認可與信心,同時將有助於公司引入更多元化的投資者,並提高在資本市場的知名度。
亞盛醫藥將繼續把握生物醫藥產業發展的重大機遇,發揮研發與運營優勢,致力於為全球患者提供安全有效的治療選擇,並努力為股東創造價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.